Price:
Rs. 14,310.00
Sample Type: PURE CULTURE
Fasting Not Requierd
Booking Procedure:
- Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
What does the AFB Drug Susceptibility Panel Comprehensive test include?
This Metropolis Healthcare test evaluates Mycobacterium tuberculosis against 13 key anti-TB drugs, covering both first-line and second-line medications for a complete resistance profile.
Why is this comprehensive susceptibility panel important?
It helps detect MDR-TB, XDR-TB, and other complex forms of drug-resistant tuberculosis, enabling doctors to plan effective treatment strategies.
Why choose Metropolis Healthcare for comprehensive TB drug testing?
Metropolis Healthcare offers advanced mycobacteriology systems, expert microbiologists, and internationally aligned quality protocols, ensuring precise and reliable susceptibility results.
What type of sample is required for this test?
A pure culture of Mycobacterium tuberculosis is required. Metropolis Healthcare uses the isolated culture to perform detailed resistance testing across 13 drugs.
Who should undergo this test at Metropolis Healthcare?
Patients suspected of drug-resistant TB, those with treatment failure, individuals with a history of incomplete therapy, or cases requiring personalized TB medication planning.
How does Metropolis Healthcare perform the 13-drug resistance analysis?
The pure culture is systematically tested against all 13 drugs under controlled laboratory conditions, using validated and standardized susceptibility testing methods.
How long does it take to receive results?
Results usually take several days, as Metropolis Healthcare performs careful incubation and interpretation to ensure clinical accuracy.
How does this test support TB treatment planning?
It identifies resistance across an extensive panel of drugs, allowing clinicians to design targeted, effective treatment regimens for complex TB cases.